Bausch Health Companies Inc. (BHC) Form 10-Q — Oct 28, 2026
Bausch Health delivered a strong Q3 2026: revenues rose to $2,941M from $2,681M a year ago, with diluted EPS of $1.15 versus $0.48, and Salix segment profit up to $716M from $570M.
Key figures
- Eps
- 1.15
- Revenue
- 2941
- Net Income
- 436
- Total Debt
- 20,637 (total long-term debt and other, incl. $866M current portion)
- Revenue Yoy
- 9.7% (Q3 2026 $2,941M vs Q3 2025 $2,681M)
- Cash Position
- 2485
- Shares Outstanding
- 374266716
- Total assets
- 25484
- Q3 diluted eps
- 1.15
- Q3 interest expense
- 398
- Bplusl ownership percent
- approximately 87%
- Q3 diluted eps prior year
- 0.48
- Goodwill impairment nine months
- 1426
- Operating cash flow nine months
- 1714
- Weighted avg stated interest rate
- 8.55%
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.